ATM and breast cancer: Studies using exome sequencing technologies in breast cancer showed a high prevalence of mutations and variants in genes such as BRCA1, BRCA2, TP53, and PIK3CA, but few reported findings for ATM (Network CGA 2012; Banerji et al. 2012).